🇺🇸 FDA
Patent

US 7820642

Nandrolone 17β-carbonates

granted A61PA61P15/00A61P15/08

Quick answer

US patent 7820642 (Nandrolone 17β-carbonates) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
62
CPC classes
A61P, A61P15/00, A61P15/08, A61P15/10, A61P15/16